$ADIL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ADIAL PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ADIAL PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ADIAL PHARMACEUTICALS, INC. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2021 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Sell | S | 2.50 | 150,000 | 375,000 | 548,336 | 698.3 K to 548.3 K (-21.48 %) |
| Apr 08 2021 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Sell | S | 2.50 | 150,000 | 375,000 | 548,336 | 698.3 K to 548.3 K (-21.48 %) |
| Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Truluck Joseph | Chief Financial Off ... | Option Exercise | A | 3.11 | 125,000 | 388,750 | 125,000 | |
| Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | A | 3.11 | 250,000 | 777,500 | 250,000 | |
| Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
| Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
| Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Goodman Tony | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
| Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
| Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Anderson J. Kermit | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
| Jan 28 2021 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Grant | A | 0.00 | 201,109 | 0 | 917,046 | 715.9 K to 917 K (+28.09 %) |
| Jan 28 2021 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Grant | A | 0.00 | 2,544 | 0 | 152,963 | 150.4 K to 153 K (+1.69 %) |
| Jan 28 2021 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Grant | A | 0.00 | 1,187 | 0 | 14,475 | 13.3 K to 14.5 K (+8.93 %) |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 5.00 | 89,600 | 448,000 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 5.00 | 89,600 | 448,000 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 82,461 | 515,381 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 82,461 | 515,381 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 89,600 | 560,000 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 89,600 | 560,000 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 89,600 | 560,000 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 89,600 | 560,000 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 7.63 | 8,649 | 65,992 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 7.63 | 8,649 | 65,992 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 0.01 | 1,010 | 5 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 0.01 | 1,010 | 5 | 0 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 5.00 | 89,600 | 448,000 | 89,600 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 5.00 | 89,600 | 448,000 | 89,600 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 82,461 | 515,381 | 82,461 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 82,461 | 515,381 | 82,461 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 89,600 | 560,000 | 89,600 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 89,600 | 560,000 | 89,600 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 89,600 | 560,000 | 89,600 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 89,600 | 560,000 | 89,600 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 7.63 | 8,649 | 65,992 | 8,649 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 7.63 | 8,649 | 65,992 | 8,649 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 0.01 | 1,010 | 5 | 1,010 | |
| Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 0.01 | 1,010 | 5 | 1,010 | |
| Aug 24 2020 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Sell | S | 1.21 | 350,000 | 423,500 | 1,055 | 351.1 K to 1.1 K (-99.70 %) |
| May 20 2020 | ADIL | ADIAL PHARMACEUTIC ... | REICH JACK W | Director | Option Exercise | A | 1.47 | 90,000 | 132,300 | 90,000 | |
| Mar 30 2020 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 1.35 | 4,644 | 6,269 | 14,644 | 10 K to 14.6 K (+46.44 %) |
| Mar 30 2020 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 1.34 | 10,000 | 13,400 | 13,288 | 3.3 K to 13.3 K (+304.14 %) |
| Mar 30 2020 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 1.42 | 5,000 | 7,100 | 15,000 | 10 K to 15 K (+50.00 %) |
| Mar 27 2020 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Buy | P | 1.47 | 12,652 | 18,598 | 715,937 | 703.3 K to 715.9 K (+1.80 %) |
| Mar 27 2020 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Buy | P | 1.13 | 12,348 | 13,953 | 703,285 | 690.9 K to 703.3 K (+1.79 %) |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Option Exercise | A | 1.44 | 60,000 | 86,400 | 60,000 | |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | A | 1.44 | 60,000 | 86,400 | 60,000 | |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | A | 1.44 | 460,000 | 662,400 | 460,000 | |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Grant | A | 0.00 | 54,167 | 0 | 690,937 | 636.8 K to 690.9 K (+8.51 %) |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Truluck Joseph | Chief Financial Off ... | Option Exercise | A | 1.44 | 20,000 | 28,800 | 200,000 | |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Truluck Joseph | Chief Financial Off ... | Grant | A | 0.00 | 27,084 | 0 | 107,639 | 80.6 K to 107.6 K (+33.62 %) |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | A | 1.44 | 60,000 | 86,400 | 60,000 | |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Goodman Tony | Director | Option Exercise | A | 1.44 | 60,000 | 86,400 | 60,000 | |
| Mar 05 2020 | ADIL | ADIAL PHARMACEUTIC ... | Anderson J. Kermit | Director | Option Exercise | A | 1.44 | 60,000 | 86,400 | 60,000 | |
| Dec 13 2019 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Sell | S | 1.00 | 150,000 | 150,000 | 698,336 | 848.3 K to 698.3 K (-17.68 %) |
| Dec 13 2019 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Sell | S | 1.00 | 150,000 | 150,000 | 698,336 | 848.3 K to 698.3 K (-17.68 %) |
| Oct 04 2019 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Grant | A | 0.00 | 3,187 | 0 | 351,055 | 347.9 K to 351.1 K (+0.92 %) |
| Apr 01 2019 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Buy | P | 3.30 | 600 | 1,978 | 347,868 | 347.3 K to 347.9 K (+0.17 %) |
| Apr 01 2019 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Buy | P | 3.47 | 2,500 | 8,669 | 347,268 | 344.8 K to 347.3 K (+0.73 %) |
| Apr 01 2019 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Buy | P | 3.47 | 30,000 | 104,154 | 344,768 | 314.8 K to 344.8 K (+9.53 %) |
| Apr 01 2019 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Buy | P | 3.15 | 40,000 | 125,808 | 314,768 | 274.8 K to 314.8 K (+14.56 %) |
| Mar 26 2019 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Option Exercise | A | 3.01 | 250,000 | 752,500 | 250,000 | |
| Mar 12 2019 | ADIL | ADIAL PHARMACEUTIC ... | Truluck Joseph | Chief Financial Off ... | Option Exercise | A | 3.39 | 180,000 | 610,200 | 180,000 | |
| Mar 12 2019 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | A | 3.39 | 500,000 | 1,695,000 | 500,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 6.25 | 162,200 | 1,013,750 | 162,200 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 5.00 | 162,200 | 811,000 | 162,200 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 5.00 | 162,200 | 811,000 | 0 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 6.25 | 120,000 | 750,000 | 120,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 5.00 | 120,000 | 600,000 | 120,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 5.00 | 120,000 | 600,000 | 0 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 92,000 | 575,000 | 92,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 92,000 | 460,000 | 92,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 92,000 | 460,000 | 0 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 20,000 | 125,000 | 20,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 20,000 | 100,000 | 20,000 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 20,000 | 100,000 | 0 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | J | 6.25 | 36,800 | 230,000 | 36,800 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | J | 5.00 | 36,800 | 184,000 | 36,800 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | J | 5.00 | 36,800 | 184,000 | 0 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Director | Option Exercise | J | 6.25 | 17,600 | 110,000 | 17,600 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Director | Option Exercise | J | 5.00 | 17,600 | 88,000 | 17,600 | |
| Nov 13 2018 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Director | Option Exercise | J | 5.00 | 17,600 | 88,000 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | P | 6.25 | 80,000 | 500,000 | 169,027 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | J | 5.00 | 36,800 | 184,000 | 36,800 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | C | 6.25 | 52,227 | 326,419 | 89,027 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | J | 6.25 | 36,800 | 230,000 | 36,800 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | C | 0.44 | 52,227 | 22,980 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Buy | P | 0.00 | 80,000 | 0 | 504,000 | 424 K to 504 K (+18.87 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Buy | C | 0.00 | 52,227 | 0 | 424,629 | 372.4 K to 424.6 K (+14.02 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Buy | J | 0.00 | 36,800 | 0 | 372,402 | 335.6 K to 372.4 K (+10.97 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 5.00 | 162,200 | 811,000 | 162,200 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 5.00 | 120,000 | 600,000 | 120,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 6.25 | 113,800 | 711,250 | 113,800 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | P | 6.25 | 90,000 | 562,500 | 292,461 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 6.25 | 120,000 | 750,000 | 202,461 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | C | 6.25 | 82,461 | 515,381 | 82,461 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | C | 0.44 | 82,461 | 36,283 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Buy | J | 0.00 | 113,800 | 0 | 113,800 | 0 to 113.8 K |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Buy | P | 0.00 | 90,000 | 0 | 343,390 | 253.4 K to 343.4 K (+35.52 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Buy | J | 0.00 | 120,000 | 0 | 253,390 | 133.4 K to 253.4 K (+89.96 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Buy | C | 0.00 | 82,461 | 0 | 133,390 | 50.9 K to 133.4 K (+161.91 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | P | 6.25 | 10,000 | 62,500 | 10,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | P | 6.25 | 10,000 | 62,500 | 102,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 92,000 | 460,000 | 92,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 20,000 | 100,000 | 20,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 92,000 | 575,000 | 92,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 20,000 | 125,000 | 25,178 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 5,178 | 32,363 | 5,178 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 21,715 | 135,719 | 21,715 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 29,931 | 187,069 | 29,931 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | C | 0.44 | 5,178 | 2,278 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | C | 0.44 | 21,715 | 9,555 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | C | 0.44 | 29,931 | 13,170 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 0.00 | 10,000 | 0 | 150,419 | 140.4 K to 150.4 K (+7.12 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | J | 0.00 | 92,000 | 0 | 140,419 | 48.4 K to 140.4 K (+190.01 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | J | 0.00 | 20,000 | 0 | 35,094 | 15.1 K to 35.1 K (+132.50 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | C | 0.00 | 5,178 | 0 | 15,221 | 10 K to 15.2 K (+51.56 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | C | 0.00 | 21,715 | 0 | 58,419 | 36.7 K to 58.4 K (+59.16 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | C | 0.00 | 29,931 | 0 | 41,160 | 11.2 K to 41.2 K (+266.55 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Goodman Tony | Director | Option Exercise | P | 6.25 | 7,000 | 43,750 | 7,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Goodman Tony | Director | Buy | P | 0.00 | 7,000 | 0 | 8,755 | 1.8 K to 8.8 K (+398.86 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Option Exercise | P | 6.25 | 14,000 | 87,500 | 43,931 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Option Exercise | C | 6.25 | 29,931 | 187,069 | 29,931 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Option Exercise | C | 0.44 | 29,931 | 13,170 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Buy | P | 0.00 | 14,000 | 0 | 109,424 | 95.4 K to 109.4 K (+14.67 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Buy | C | 0.00 | 29,931 | 0 | 95,424 | 65.5 K to 95.4 K (+45.70 %) |
Page: 1